Phibro Animal Health Corp. (PAHC)
37.66
+1.31
(+3.60%)
USD |
NASDAQ |
Aug 28, 16:00
37.66
0.00 (0.00%)
After-Hours: 17:48
Phibro Animal Health Cash from Operations (Quarterly) : 24.09M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.09M |
| March 31, 2026 | 16.21M |
| December 31, 2025 | 19.35M |
| September 30, 2025 | 9.302M |
| June 30, 2025 | 21.27M |
| March 31, 2025 | 43.15M |
| December 31, 2024 | 3.076M |
| September 30, 2024 | 12.62M |
| June 30, 2024 | 28.43M |
| March 31, 2024 | 11.41M |
| December 31, 2023 | 31.56M |
| September 30, 2023 | 16.20M |
| June 30, 2023 | 20.24M |
| March 31, 2023 | 6.259M |
| December 31, 2022 | -2.489M |
| September 30, 2022 | -10.70M |
| June 30, 2022 | 1.574M |
| March 31, 2022 | 6.132M |
| December 31, 2021 | 20.12M |
| September 30, 2021 | 3.821M |
| June 30, 2021 | 3.07M |
| March 31, 2021 | 16.62M |
| December 31, 2020 | 26.91M |
| September 30, 2020 | 1.698M |
| June 30, 2020 | 3.877M |
| Date | Value |
|---|---|
| March 31, 2020 | 26.95M |
| December 31, 2019 | 32.09M |
| September 30, 2019 | -3.57M |
| June 30, 2019 | 14.88M |
| March 31, 2019 | 15.65M |
| December 31, 2018 | 15.36M |
| September 30, 2018 | 1.28M |
| June 30, 2018 | 10.11M |
| March 31, 2018 | 22.81M |
| December 31, 2017 | 32.29M |
| September 30, 2017 | 4.803M |
| June 30, 2017 | 13.58M |
| March 31, 2017 | 37.08M |
| December 31, 2016 | 26.28M |
| September 30, 2016 | 21.46M |
| June 30, 2016 | 26.59M |
| March 31, 2016 | 5.022M |
| December 31, 2015 | 7.998M |
| September 30, 2015 | -2.394M |
| June 30, 2015 | 21.86M |
| March 31, 2015 | 21.08M |
| December 31, 2014 | 8.403M |
| September 30, 2014 | 17.36M |
| June 30, 2014 | -17.34M |
| March 31, 2014 | 0.233M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Zoetis, Inc. | 655.00M |
| Merck & Co., Inc. | 5.37B |
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
| Veru, Inc. | -5.467M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -16.45M |
| Cash from Financing (Quarterly) | -1.615M |
| Free Cash Flow | 9.866M |
| Free Cash Flow Per Share (Quarterly) | 0.1274 |
| Free Cash Flow to Equity (Quarterly) | 3.902M |
| Free Cash Flow to Firm (Quarterly) | 5.579M |
| Free Cash Flow Yield | 0.64% |